Close Menu

University of Vermont

In PLOS this week: genome-wide association study of epigenetic age acceleration, antimicrobial resistance genes found in organic egg farm samples, and more.

Invitae is providing the testing services as part of the 12-month pilot, while patients will have the option to share their results with researchers though LunaDNA.

In Genome Research this week: mutational signature linked to acrylamide exposure, computational platform for identifying viral integrations in cancer, and more.

Data from almost 19,500 individuals did not show clear ties between a heterozygous mutation in the HBB hemoglobin beta gene and ischemic stroke risk.

As PierianDx grows, two customers weighed in on their experiences with the core product, the Clinical Genomicist Workspace, and its NGS-related services.

The organizations in the consortium will identify, characterize, and catalog human biological molecules affected by physical activity in volunteer biosamples.

Metagenomic tools are shedding light on how microbes survive in and contribute to environments ranging from wetlands to natural oil seepage sites, according to presentations at this year's ABRF meeting.

In an assessment using standardized RNA samples, sequencing platforms showed both intra-platform reliability and inter-platform agreement, according to findings presented by an Association of Biomedical Resource Facilities working group at the organization's annual meeting last w

Sarkar, who is director of biomedical informatics at the University of Vermont's Center for Clinical and Translational Science, said biomedical informaticians should be involved wherever translational barriers need to be surmounted.

The subsidiary, MetaCytoLytics, will commercialize cancer therapies based on metabolic disruption technology developed at the University of Colorado and the University of Vermont by the same inventor.

Pages

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.